×

ENTER REPORT NAME TO SEARCH

Global Phenotypic Drug Discovery Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212270083 | Category: Service & Software | Pages: 86 | Format: PDF | Published Date: February 04,2023


Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Phenotypic Drug Discovery
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Phenotypic Drug Discovery by Type
        1.3.1 Overview: Global Phenotypic Drug Discovery Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Phenotypic Drug Discovery Consumption Value Market Share by Type in 2022
        1.3.3 Platform
        1.3.4 Service
    1.4 Global Phenotypic Drug Discovery Market by Application
        1.4.1 Overview: Global Phenotypic Drug Discovery Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Cancer
        1.4.3 Viral Infection
        1.4.4 Genetic Disease
        1.4.5 Others
    1.5 Global Phenotypic Drug Discovery Market Size & Forecast
    1.6 Global Phenotypic Drug Discovery Market Size and Forecast by Region
        1.6.1 Global Phenotypic Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Phenotypic Drug Discovery Market Size by Region, (2018-2029)
        1.6.3 North America Phenotypic Drug Discovery Market Size and Prospect (2018-2029)
        1.6.4 Europe Phenotypic Drug Discovery Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Phenotypic Drug Discovery Market Size and Prospect (2018-2029)
        1.6.6 South America Phenotypic Drug Discovery Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Phenotypic Drug Discovery Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Eurofins Discovery
        2.1.1 Eurofins Discovery Details
        2.1.2 Eurofins Discovery Major Business
        2.1.3 Eurofins Discovery Phenotypic Drug Discovery Product and Solutions
        2.1.4 Eurofins Discovery Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Eurofins Discovery Recent Developments and Future Plans
    2.2 Sygnature Discovery
        2.2.1 Sygnature Discovery Details
        2.2.2 Sygnature Discovery Major Business
        2.2.3 Sygnature Discovery Phenotypic Drug Discovery Product and Solutions
        2.2.4 Sygnature Discovery Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Sygnature Discovery Recent Developments and Future Plans
    2.3 PsychoGenics
        2.3.1 PsychoGenics Details
        2.3.2 PsychoGenics Major Business
        2.3.3 PsychoGenics Phenotypic Drug Discovery Product and Solutions
        2.3.4 PsychoGenics Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 PsychoGenics Recent Developments and Future Plans
    2.4 siTOOLs Biotech
        2.4.1 siTOOLs Biotech Details
        2.4.2 siTOOLs Biotech Major Business
        2.4.3 siTOOLs Biotech Phenotypic Drug Discovery Product and Solutions
        2.4.4 siTOOLs Biotech Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 siTOOLs Biotech Recent Developments and Future Plans
    2.5 PhoreMost
        2.5.1 PhoreMost Details
        2.5.2 PhoreMost Major Business
        2.5.3 PhoreMost Phenotypic Drug Discovery Product and Solutions
        2.5.4 PhoreMost Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 PhoreMost Recent Developments and Future Plans
    2.6 Charles River
        2.6.1 Charles River Details
        2.6.2 Charles River Major Business
        2.6.3 Charles River Phenotypic Drug Discovery Product and Solutions
        2.6.4 Charles River Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Charles River Recent Developments and Future Plans
    2.7 MaxWell
        2.7.1 MaxWell Details
        2.7.2 MaxWell Major Business
        2.7.3 MaxWell Phenotypic Drug Discovery Product and Solutions
        2.7.4 MaxWell Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 MaxWell Recent Developments and Future Plans
    2.8 Arctoris
        2.8.1 Arctoris Details
        2.8.2 Arctoris Major Business
        2.8.3 Arctoris Phenotypic Drug Discovery Product and Solutions
        2.8.4 Arctoris Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Arctoris Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Phenotypic Drug Discovery Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Phenotypic Drug Discovery by Company Revenue
        3.2.2 Top 3 Phenotypic Drug Discovery Players Market Share in 2022
        3.2.3 Top 6 Phenotypic Drug Discovery Players Market Share in 2022
    3.3 Phenotypic Drug Discovery Market: Overall Company Footprint Analysis
        3.3.1 Phenotypic Drug Discovery Market: Region Footprint
        3.3.2 Phenotypic Drug Discovery Market: Company Product Type Footprint
        3.3.3 Phenotypic Drug Discovery Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Phenotypic Drug Discovery Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Phenotypic Drug Discovery Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Phenotypic Drug Discovery Consumption Value Market Share by Application (2018-2023)
    5.2 Global Phenotypic Drug Discovery Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Phenotypic Drug Discovery Consumption Value by Type (2018-2029)
    6.2 North America Phenotypic Drug Discovery Consumption Value by Application (2018-2029)
    6.3 North America Phenotypic Drug Discovery Market Size by Country
        6.3.1 North America Phenotypic Drug Discovery Consumption Value by Country (2018-2029)
        6.3.2 United States Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        6.3.3 Canada Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        6.3.4 Mexico Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Phenotypic Drug Discovery Consumption Value by Type (2018-2029)
    7.2 Europe Phenotypic Drug Discovery Consumption Value by Application (2018-2029)
    7.3 Europe Phenotypic Drug Discovery Market Size by Country
        7.3.1 Europe Phenotypic Drug Discovery Consumption Value by Country (2018-2029)
        7.3.2 Germany Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        7.3.3 France Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        7.3.5 Russia Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        7.3.6 Italy Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Phenotypic Drug Discovery Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Phenotypic Drug Discovery Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Region
        8.3.1 Asia-Pacific Phenotypic Drug Discovery Consumption Value by Region (2018-2029)
        8.3.2 China Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        8.3.3 Japan Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        8.3.4 South Korea Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        8.3.5 India Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        8.3.7 Australia Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Phenotypic Drug Discovery Consumption Value by Type (2018-2029)
    9.2 South America Phenotypic Drug Discovery Consumption Value by Application (2018-2029)
    9.3 South America Phenotypic Drug Discovery Market Size by Country
        9.3.1 South America Phenotypic Drug Discovery Consumption Value by Country (2018-2029)
        9.3.2 Brazil Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        9.3.3 Argentina Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Phenotypic Drug Discovery Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Phenotypic Drug Discovery Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country
        10.3.1 Middle East & Africa Phenotypic Drug Discovery Consumption Value by Country (2018-2029)
        10.3.2 Turkey Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
        10.3.4 UAE Phenotypic Drug Discovery Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Phenotypic Drug Discovery Market Drivers
    11.2 Phenotypic Drug Discovery Market Restraints
    11.3 Phenotypic Drug Discovery Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Phenotypic Drug Discovery Industry Chain
    12.2 Phenotypic Drug Discovery Upstream Analysis
    12.3 Phenotypic Drug Discovery Midstream Analysis
    12.4 Phenotypic Drug Discovery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

It contains all the geographic trends, and market analysis for global market